7月A股开门红，创新药板块受青睐

Group 1 - The A-share market experienced a positive start in July, with the Shanghai Composite Index rising by 0.39%, the Shenzhen Component Index increasing by 0.11%, and the ChiNext Index declining by 0.24%, marking a new closing high for the year [1] - The total trading volume in the Shanghai and Shenzhen markets reached 14,660 billion yuan, a decrease of 208 billion yuan compared to the previous day [1] - The market sentiment improved, driven by the banking sector, and the overall market is close to the high point reached on June 26 [1] Group 2 - The market has broken the "five poor and six absolute" curse, with the financial sector performing well [1] - The current market trend is characterized by a healthy "advance three, retreat two" pattern, indicating signs of a slow bull market [1] - Main funds have recently concentrated on the pharmaceutical industry chain, with the innovative drug sector experiencing a broad increase [1] Group 3 - The positive developments are attributed to the issuance of 16 measures by two departments to support the high-quality development of innovative drugs [1] - Leading stocks in the innovative drug sector have shown impressive performance, with Dongyangguang in the pharmaceutical sector hitting a new high [1]